IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1
By Aihua Li, S. Dubey, M. Varney, B. Dave, Rakesh K. Singh. Journal of Immunology, 2003
1,370 citations recorded by the source corpus.
Subfields: Immunology and Allergy, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/004e65afbda3b4eaed0977787051a82a3130456e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- V. Arana-Argáez
- J. Lara-Riegos
- Saray Quintero-Fabián
- E. Becerril-Villanueva
- M. Álvarez-Sánchez
- J. Torres-Romero
- M. Ramírez-Camacho
- Rodrigo Arreola
Citations in the corpus
- Role of Matrix Metalloproteinases in Angiogenesis and Cancer (2019, background): “TNF-α, IL-8 and other factors with a known pro-angiogenic capacity, stimulate the production of MMP-2,−8, and−9 in ECs and regulate the angiogenesis process (63, 112).”
- The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. (2005, background): “The proangiogenic effects of IL-8 additionally stem from its ability to inhibit the apoptosis of endothelial cells (Li et al., 2003).”
- Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases (2017, neutral): “For example, upon CXCL8 stimulation, endothelial cells begin the angiogenic process by secreting matrix metalloproteinases (MMPs) to break down the extracellular matrix (ECM) and start to proliferate and initiate the formation of capillaries [245].”